Forums » News
- Topic
- Posted By
- Last Post
- Replies
- As blockbuster drugs fade, so does TV advertising
- News
- 03rd February, 15:53
- 0
- AZ cuts do not put UK life sciences sector at risk - ABPI
- News
- 03rd February, 15:50
- 0
- Merck KGaA signs $550 million cancer pact with Threshold
- News
- 03rd February, 15:42
- 0
- Drug Shortages Cause Cancer Patients To Die Sooner
- News
- 03rd February, 09:04
- 0
- Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results
- News
- 03rd February, 08:59
- 0
- Czechs beef up investment in biotech research
- News
- 03rd February, 08:57
- 0
- Novo amps up 2012 expectations on strong Victoza sales
- News
- 03rd February, 08:51
- 0
- GlaxoSmithKline (GSK) Settles 20,000 Lawsuits Over Avandia, Lawyer Says
- News
- 03rd February, 08:14
- 0
- The Pfizer Generation: Who Pays For The Babies?
- News
- 02nd February, 15:47
- 0
- Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results
- News
- 02nd February, 15:35
- 0
- EU Commission tells Italy: "comply with rules on generics"
- News
- 02nd February, 15:33
- 0
- Universal flu vaccine might be step closer
- News
- 02nd February, 15:30
- 0
- Analysis: Pharmaceutical woes
- News
- 02nd February, 15:21
- 0
- Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction
- News
- 02nd February, 09:34
- 0
- AstraZeneca axes 7,300 jobs as growth stalls
- News
- 02nd February, 09:30
- 0
- Pakistan drug manufacturers make plea for oversight
- News
- 02nd February, 07:06
- 0
- Medivation, Inc. Soars as Prostate Cancer Drug is Well-tolerated in Phase 3 Trial
- News
- 02nd February, 06:59
- 0
- No need to loosen conflict rules, U.S. FDA head says
- News
- 02nd February, 06:55
- 0
- Cancer drug 'too expensive for NHS'
- News
- 02nd February, 06:43
- 0
- Pfizer recalls 1 million packets of US birth control pills
- News
- 01st February, 17:11
- 0
- Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
- News
- 01st February, 17:04
- 0
- Dendreon Announces CEO and Chairman Succession Plan
- News
- 01st February, 17:02
- 0
- Roche places bets on new products for 2012 growth
- News
- 01st February, 17:00
- 0
- Sanofi trims staff at Genzyme R&D as it builds Boston hub
- News
- 01st February, 16:53
- 0
- Vertex nabs expedited FDA OK on breakthrough CF drug
- News
- 01st February, 07:17
- 0
- WSJ: Another executive shake-up at J&J's McNeil unit
- News
- 01st February, 07:13
- 0
- Sanger Institute survey tests waters on genomic data use
- News
- 01st February, 07:10
- 0
- Pfizer profits battered as generic Lipitor hits US market
- News
- 01st February, 07:02
- 0
- FDA approves Vertex cystic fibrosis drug Kalydeco

- News
- 01st February, 06:59
- 0
- J&J Reorganizes Consumer Health Unit, Again
- News
- 31st January, 17:06
- 0